Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
BPC 157 entered early-phase clinical development for inflammatory bowel disease as PL 14736 (Pliva, Croatia), and a 2025 pilot examined intravenous administration in a small cohort, but no adequately powered randomised controlled trial exists
10.1016/j.jalz.2019.01.010 9 AmaseneM.BesgaA.EcheverriaI.UrquizaM.RuizJ
FDA-MOCRA Registered
Fast, reliable shipping ensures you receive your items hassle-free
US$ 24.14
US$ 21.66
US$ 28.89
US$ 21.72
